Impact of Clinical Pharmacy Service on Patient Care and Cost Saving (TGPIONEER)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02861677|
Recruitment Status : Unknown
Verified August 2016 by Tigestu Alemu, Jimma University.
Recruitment status was: Not yet recruiting
First Posted : August 10, 2016
Last Update Posted : August 10, 2016
Background: Pharmacists have been proven to improve patient outcomes, medication adherence, glycemic control, reduce blood pressure, low-density lipoprotein, health care costs and length of hospital stay, and enhance quality of life.
Objective: to measure the impact of clinical pharmacy service on patient care and cost saving of patients at inpatient wards and ambulatory care clinics of Jimma University Specialized Hospital.
Methods: single center Randomized Controlled Trial will be conducted. Participants will be assigned to either pharmacy professionals' intervention group or non-intervention (control) group based on computer generated random number. The study will be done from July 26 to September 15, 2016. The total sample size is calculated with Open Epi online sample size calculator with 95% CI and 80% power. The total sample size is found to be 146 for inpatients and 473 for outpatients. Linear regression, student's t-test, logistic regression and chi-square test will be used for statistical analysis. Variables with p<0.05 will be considered statistically significant.
|Condition or disease||Intervention/treatment||Phase|
|Health Care Improvement||Other: pharmaceutical care||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||576 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Health Services Research|
|Official Title:||Impact of Clinical Pharmacy Service on Patient Care and Cost Saving|
|Study Start Date :||August 2016|
|Estimated Primary Completion Date :||September 2016|
|Estimated Study Completion Date :||September 2016|
No Intervention: Control group
The control group will receive the usual medical care by physicians and nurses
Experimental: Intervention group
the intervention group will receive clinical pharmacy services
Other: pharmaceutical care
- The number of drug therapy problems [ Time Frame: through study completion, an average of 8 weeks ]
- The number of medication errors [ Time Frame: through study completion, an average of 8 weeks ]
- Cost of medicines [ Time Frame: through study completion, an average of 8 weeks ]
- Length of hospital stay [ Time Frame: through study completion, an average of 8 weeks ]
- In hospital mortality [ Time Frame: through study completion, an average of 8 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02861677
|Contact: Tigestu Desse, MScfirstname.lastname@example.org|